SigmaPharm Looks To Relaunch Skelaxin Antitrust Battle

Law360, Philadelphia (October 31, 2012, 9:31 PM EDT) -- SigmaPharm Inc. on Wednesday sought a fresh start in its long-running antitrust fight with King Pharmaceuticals Inc. and Mutual Pharmaceutical Co. Inc., which it accuses of masterminding a conspiracy to suppress the release of generic forms of the muscle relaxer Skelaxin and to rob it of millions in royalties.

The drugmaker's racketeering suit, filed in Pennsylvania federal court, is part of a simmering feud among SigmaPharm, King and Mutual over sales of King's Skelaxin. The suit alleges the companies conspired to keep SigmaPharm from its rightful share of...
To view the full article, register now.